Australian biotech market today 23.04.09
Thursday, 23 April, 2009
A very flat day’s trading on the healthcare index today, in line with the rest of stocks, which were generally in the positive but volumes were small.
Biota (ASX:BTA) is up 12c on news that royalties from Relenza for the quarter will total $32.3 million.
Circadian (ASX:CIR) was up 3c, as was Clinuvel (ASX:CLV), up 2c to 32c.
Cochlear (ASX:COH) was substantially down again, to $48.3, while Pharmaxis (ASX:PXS) was up a touch.
Diversa (ASX:DVA) was up slightly on its reinstatement to trading.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
